ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

President Accepts Rauscher Resignation

October 1, 1976

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Eye Institute Director Kupfer Steps Down; UICC Begins Web-Based Surgical Pathology.

July 7, 2000

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986